Met Life Investment Management, LLC Cytosorbents Corp Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.05 - $8.11 $62,467 - $125,088	-15,424 Closed	0 $0
Q3 2021 May 17, 2024	SELL	$7.0 - $9.71 $15,806 - $21,925	-2,258 Reduced 12.77%	15,424 $125,000
Q3 2021 Jun 21, 2023	BUY	$7.0 - $9.71 $107,968 - $149,767	15,424 New	15,424 $125,000
Q3 2021 Mar 22, 2023	SELL	$7.0 - $9.71 $15,806 - $21,925	-2,258 Reduced 12.77%	15,424 $125,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $107,968 - $149,767	15,424 New	15,424 $125,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $133,499 - $166,564	-17,682 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$8.23 - $11.48 $145,522 - $202,989	17,682 New	17,682 $153,000
Q1 2021 Jun 26, 2023	BUY	$8.23 - $11.48 $145,522 - $202,989	17,682 New	17,682 $153 Million
Q1 2021 Mar 22, 2023	BUY	$8.23 - $11.48 $22,270 - $31,064	2,706 Added 18.07%	17,682 $153,000
Q1 2021 May 14, 2021	BUY	$8.23 - $11.48 $22,270 - $31,064	2,706 Added 18.07%	17,682 $153,000
Q4 2020 Jun 22, 2023	BUY	$7.65 - $8.98 $114,566 - $134,484	14,976 New	14,976 $119,000
Q3 2020 Jun 26, 2023	BUY	$7.37 - $11.54 $110,373 - $172,823	14,976 New	14,976 $119,000
Q2 2020 May 24, 2024	BUY	$6.28 - $10.59 $94,049 - $158,595	14,976 New	14,976 $148 Million
Q2 2020 Jun 26, 2023	BUY	$6.28 - $10.59 $94,049 - $158,595	14,976 New	14,976 $148,000
Q2 2020 Mar 22, 2023	BUY	$6.28 - $10.59 $1,199 - $2,022	191 Added 1.29%	14,976 $148,000
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $94,049 - $158,595	14,976 New	14,976 $148,000
Q2 2019 Jul 12, 2023	BUY	$5.92 - $7.78 $87,527 - $115,027	14,785 New	14,785 $97.7 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.78 $87,527 - $115,027	-14,785 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$6.82 - $8.56 $100,833 - $126,559	14,785 New	14,785 $111,000
Q4 2018 Jul 13, 2023	BUY	$7.05 - $12.64 $104,234 - $186,882	14,785 New	14,785 $119,000
Q4 2018 Mar 22, 2023	SELL	$7.05 - $12.64 $57,492 - $103,079	-8,155 Reduced 35.55%	14,785 $119,000
Q4 2018 Feb 14, 2019	SELL	$7.05 - $12.64 $57,492 - $103,079	-8,155 Reduced 35.55%	14,785 $119,000
Q3 2018 Jul 13, 2023	BUY	$10.95 - $14.8 $161,895 - $218,818	14,785 New	14,785 $190,000
Q3 2018 Mar 22, 2023	BUY	$10.95 - $14.8 $251,192 - $339,512	22,940 New	22,940 $295,000
Q3 2018 Nov 14, 2018	BUY	$10.95 - $14.8 $89,297 - $120,694	8,155 Added 55.16%	22,940 $296,000
Q2 2018 Aug 15, 2018	BUY	$6.9 - $12.35 $102,016 - $182,594	14,785 New	14,785 $169,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.9M

Call Options Held

10.1K

Put Options Held

500

Avenir Corp Washington, DC

2.97M
Shares

$3.53 Million
0.21% of portfolio
Skylands Capital, LLC

2.84M
Shares

$3.38 Million
0.3% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.66M
Shares

$3.17 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$2.32 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.54M
Shares

$1.83 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account